Bottom line
PHSZX vs HGHAX: the short answer
PHSZX (PGIM Jennison Health Sciences Fund) and HGHAX (The Hartford Healthcare Fund) are both mutual funds.
PHSZX is cheaper at 0.88% vs 1.33% — a difference of $45 a year per $10,000 invested.
HGHAX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
PHSZX vs HGHAX side by side
| PHSZX | HGHAX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | PGIM (Prudential) | Hartford |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.88% | 1.33% |
| Annual cost per $10k | $88 | $133 |
| 10-yr cost on $10k (prospectus) | $1,084 | $2,063 |
| Max front load | 0% | 5.5% |
| 12b-1 fee | 0% | 0.25% |
| 1-yr return | +19.6% | — |
| 5-yr return (annualized) | +7.0% | — |
| 10-yr return (annualized) | +9.8% | — |
| Best quarter | +29.7% | +20.9% |
| Worst quarter | −20.5% | −15.7% |
| Net assets (fund) | $1.4B | $772.2M |
| Number of holdings | 55 | 80 |
| Portfolio turnover | 81% | 49% |
| Returns as of | Dec 31, 2024 | — |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | PHSZX | HGHAX | Difference |
|---|---|---|---|
| 2024 | +19.6% | 0.0% | +19.6% |
| 2023 | +8.8% | +3.8% | +5.0% |
| 2022 | +12.6% | −11.7% | +24.4% |
| 2021 | −10.1% | +10.0% | −20.0% |
| 2020 | +6.3% | +22.6% | −16.3% |
| 2019 | +41.7% | +33.3% | +8.4% |
| 2018 | +18.6% | −3.0% | +21.6% |
| 2017 | −3.4% | +21.6% | −25.0% |
| 2016 | +31.4% | −8.6% | +40.0% |
Source: Fund prospectus bar charts
Holdings overlap
10 of PHSZX's top 25 holdings also appear in HGHAX's top 25.
| Holding | PHSZX | HGHAX |
|---|---|---|
| Eli Lilly & Company | 17.35% | 12.03% |
| Merck & Company Inc | 6.06% | 6.00% |
| Unitedhealth Group Inc | 5.87% | 4.74% |
| Thermo Fisher Scientific Inc | 4.56% | 1.58% |
| Vertex Pharmaceuticals Inc | 3.37% | 2.64% |
| Danaher Corp | 3.28% | 2.57% |
| Intuitive Surgical Inc | 3.07% | 2.88% |
| Cvs Health Corp | 2.52% | 2.84% |
| Stryker Corp | 2.16% | 1.24% |
| Agilent Technologies Inc | 1.73% | 1.54% |
Source: SEC Form N-PORT
PHSZX top 10
- Eli Lilly & Company — 17.35%
- Merck & Company Inc — 6.06%
- Unitedhealth Group Inc — 5.87%
- Thermo Fisher Scientific Inc — 4.56%
- Argenx Se — 3.55%
- Vertex Pharmaceuticals Inc — 3.37%
- Danaher Corp — 3.28%
- Intuitive Surgical Inc — 3.07%
- Lonza Group Ag — 3.02%
- Cvs Health Corp — 2.52%
HGHAX top 10
- Eli Lilly & Co — 12.03%
- Johnson & Johnson — 6.75%
- Merck & Co Inc — 6.00%
- UnitedHealth Group Inc — 4.74%
- AbbVie Inc — 4.21%
- Elevance Health Inc — 3.00%
- Intuitive Surgical Inc — 2.88%
- CVS Health Corp — 2.84%
- Vertex Pharmaceuticals Inc — 2.64%
- Danaher Corp — 2.57%
FAQ
What is the difference between PHSZX and HGHAX?
Which is cheaper, PHSZX or HGHAX?
Should I own both PHSZX and HGHAX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.